Ankui Yang

1.3k total citations
63 papers, 816 citations indexed

About

Ankui Yang is a scholar working on Surgery, Otorhinolaryngology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ankui Yang has authored 63 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 23 papers in Otorhinolaryngology and 23 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ankui Yang's work include Head and Neck Cancer Studies (23 papers), Thyroid Cancer Diagnosis and Treatment (23 papers) and Head and Neck Surgical Oncology (9 papers). Ankui Yang is often cited by papers focused on Head and Neck Cancer Studies (23 papers), Thyroid Cancer Diagnosis and Treatment (23 papers) and Head and Neck Surgical Oncology (9 papers). Ankui Yang collaborates with scholars based in China, United States and South Korea. Ankui Yang's co-authors include Xuan Su, Dian Ouyang, Weichao Chen, Xiaoyan Fu, Yanchun Lv, Xuewen Liu, Rong Zhang, Chuanmiao Xie, Hui Li and Ming‐Yuan Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ankui Yang

59 papers receiving 807 citations

Peers

Ankui Yang

SURGE

EDM

OTORH

ONCOL

Mark L. C. Khoo Singapore

Bénédicte Brounais-Le Royer France

Hongbo Shan China

David J.D. Perrins United Kingdom

Yushun Gao China

Yufeng Luo China

Kwang Wook Suh South Korea

Mario Piazza Italy

Yong Bao China

Leonardo S. Lino‐Silva Mexico

Mark L. C. Khoo Singapore

Ankui Yang

280 ×1.0

SURGE

417 ×2.0

EDM

47 ×0.2

OTORH

123 ×0.6

185 ×1.0

ONCOL

Citations per year, relative to Ankui Yang Ankui Yang (= 1×) peers Mark L. C. Khoo

Countries citing papers authored by Ankui Yang

Since Specialization

Citations

This map shows the geographic impact of Ankui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankui Yang more than expected).

Fields of papers citing papers by Ankui Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankui Yang. The network helps show where Ankui Yang may publish in the future.

Co-authorship network of co-authors of Ankui Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ankui Yang. A scholar is included among the top collaborators of Ankui Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankui Yang. Ankui Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tian, Xin, Rujiao Liu, Long Zhang, et al.. (2025). Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Human Monoclonal Antibody TQC2731 Targeting Thymic Stromal Lymphopoietin (TSLP) in Health Chinese Adults. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3424–A3424. 1 indexed citations

Chen, Shu-Wei, Xing Zhang, Hui Li, et al.. (2024). Neoadjuvant sintilimab and platinum-doublet chemotherapy followed by transoral robotic surgery for HPV-associated resectable oropharyngeal cancer: Single-arm, phase II trial.. Journal of Clinical Oncology. 42(16_suppl). 6011–6011. 2 indexed citations

Zheng, Xiangqian, Meiyu Fang, Yun Fan, et al.. (2024). Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients. Endocrine Related Cancer. 31(4). 3 indexed citations

Liang, Xinling, Jianteng Xie, Yanning Zhang, et al.. (2024). Enarodustat for the Treatment of Anemia in Chinese Patients with Non-Dialysis Chronic Kidney Disease: A Phase 3 Trial. SHILAP Revista de lepidopterología. 11(1). 49–62.

Yu, Yongchao, Ning Kang, Xinyu Liu, et al.. (2024). Effectiveness of prognostic nutritional index in predicting overall survival and evaluating immunotherapy response in anaplastic thyroid carcinoma. Endocrine. 86(1). 246–254. 1 indexed citations

Xie, Haojun, Mingjie Jiang, Ke Jiang, et al.. (2024). Communication between cancer cell subtypes by exosomes contributes to nasopharyngeal carcinoma metastasis and poor prognosis. Precision Clinical Medicine. 7(3). pbae018–pbae018. 2 indexed citations

Li, Yin, et al.. (2023). Risk factors and predictive model for recurrence in papillary thyroid carcinoma: a single-center retrospective cohort study based on 955 cases. Frontiers in Endocrinology. 14. 1268282–1268282. 7 indexed citations

Liu, Lili, Lijun Wei, Wenmei Jiang, et al.. (2023). Neoadjuvant chemoimmunotherapy shows major pathological response and low recurrence in head and neck squamous cell carcinoma. Clinical & Translational Oncology. 26(5). 1192–1202. 5 indexed citations

Fu, Lingyi, Sen Li, Weiwei Xiao, et al.. (2021). DGKA Mediates Resistance to PD-1 Blockade. Cancer Immunology Research. 9(4). 371–385. 23 indexed citations

10.

Su, Xuan, Huichan He, Zu‐Lu Ye, et al.. (2020). A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal Cancers. Frontiers in Oncology. 10. 535893–535893. 10 indexed citations

11.

Su, Xuan, Da‐Lei Zhou, Zu‐Lu Ye, et al.. (2020). Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancer. Genomics. 112(6). 4959–4967. 10 indexed citations

12.

Fu, Xiaoyan, Huayong Zhang, Zhipeng Chen, et al.. (2019). TFAP2B overexpression contributes to tumor growth and progression of thyroid cancer through the COX-2 signaling pathway. Cell Death and Disease. 10(6). 397–397. 29 indexed citations

13.

Liu, Tianrun, et al.. (2017). Discrepancy between cTNM stage and postoperative pTNM stage of oral squamous cell carcinoma. 2(3). 1 indexed citations

14.

Liu, Tianrun, et al.. (2017). A clinical analysis of retropharyngeal lymph node metastasis from oral tongue carcinoma. 2(4). 1 indexed citations

15.

Su, Xuan, Caiyun He, Tao Tang, et al.. (2016). Sequential four-drug chemotherapy and intensity-modulated radiotherapy for larynx preservation in resectable advanced larynx and hypopharynx cancer: A pilot study. American Journal of Otolaryngology. 38(1). 52–56. 1 indexed citations

16.

Liu, Xuewen, Dian Ouyang, Hui Li, et al.. (2014). Papillary Thyroid Cancer: Dual-Energy Spectral CT Quantitative Parameters for Preoperative Diagnosis of Metastasis to the Cervical Lymph Nodes. Radiology. 275(1). 167–176. 126 indexed citations

17.

Song, Ming, et al.. (2013). Mandibular lingual release approach: an appropriate approach for total or subtotal glossectomy. Head & Neck Oncology. 5(2). 5 indexed citations

18.

Liu, Xubao, et al.. (2013). Treatments for complications of tracheal sleeve resection for papillary thyroid carcinoma with tracheal invasion. European Journal of Surgical Oncology. 40(2). 176–181. 21 indexed citations

19.

Li, Quan, Xuekui Liu, Weiwei Liu, et al.. (2010). The Impact of Cervical Metastasis on the Prognosis of Squamous Cell Carcinoma of the Hard Palate. Clinical Oncology and Cancer Research. 37(19). 1119–1122. 1 indexed citations

20.

Chen, Ming‐Yuan, Weiping Wen, Xiang Guo, et al.. (2009). Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma. The Laryngoscope. 119(3). 516–522. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact